(VIANEWS) - Stantec (STN), Charles River Laboratories (CRL), Amphastar Pharmaceuticals (AMPH) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Stantec (STN)
20.3% sales growth and 9.87% return on equity
Stantec Inc. offers professional consulting services for infrastructure and facility management in Canada, America, and around the world.
Stantec's sales growth this year is anticipated to be 18.7% and 6.3% for next year.
Year-on-year quarterly revenue growth grew by 19.5%, now sitting on 3.81B for the twelve trailing months.
Volume
Today's last reported volume for Stantec is 45588 which is 45.23% below its average volume of 83240.
Stantec's sales growth for the next quarter is 20.3%. The company's growth estimates for the present quarter and the next is 24% and 19.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.87%.
Volatility
Stantec's last day, last week, and last month's current intraday variation average was 0.69%, 1.55%, and 1.42%, respectively.
Stantec's highest amplitude of average volatility was 1.31% (day), 2.26% (last week), and 2.19% (last month), respectively.
Stantec's Stock Yearly Top and Bottom Value
Stantec's stock is valued at $42.32 at 11:22 EST, way under its 52-week high of $58.50 and above its 52-week low of $40.92.
Stantec's Moving Average
Stantec's worth is under its 50-day moving average of $45.74 and way under its 200-day moving average of $50.74.2. Charles River Laboratories (CRL)
17.6% sales growth and 18.37% return on equity
Charles River Laboratories International, Inc. is an early-stage contract-research company that provides services for drug discovery, safety testing, and non-clinical research.
Charles River Laboratories's sales growth this year is anticipated to be 22.2% and 11.9% for next year.
Year-on-year quarterly revenue growth grew by 20.5%, now sitting on 3.43B for the twelve trailing months.
Volume
Today's last reported volume for Charles River Laboratories is 337564 which is 38.27% below its average volume of 546850.
Charles River Laboratories's sales growth for the next quarter is 17.6%. The company's growth estimates for the present quarter and the next is 10.7% and 7.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.37%.
Volatility
Charles River Laboratories's last day, last week, and last month's current intraday variation average was 2.60%, 3.21%, and 2.52%, respectively.
Charles River Laboratories's highest amplitude of average volatility was 2.82% (day), 4.05% (last week), and 3.40% (last month), respectively.
Charles River Laboratories's Stock Yearly Top and Bottom Value
Charles River Laboratories's stock is valued at $226.16 at 11:22 EST, below its 52-week low of $237.27.
Charles River Laboratories's Moving Average
Charles River Laboratories's worth is way under its 50-day moving average of $393.86 and way below its 200-day moving average of $371.52.3. Amphastar Pharmaceuticals (AMPH)
14% sales growth and 14.16% return on equity
Amphastar Pharmaceuticals, Inc., is a specialty pharmaceutical firm that develops, manufactures, market and sells intranasal, injectable, and inhalation products. It operates in France, China, the United States, and France.
Amphastar Pharmaceuticals's sales growth this year is anticipated to be 14.4% and 9.1% for next year.
Year-on-year quarterly revenue growth grew by 26%, now sitting on 437.77M for the twelve trailing months.
Volume
Today's last reported volume for Amphastar Pharmaceuticals is 271516 which is 54.74% below its average volume of 600024.
Amphastar Pharmaceuticals's sales growth is a negative 0% for the current quarter and 14% for the next. The company's growth estimates for the ongoing quarter and the next is 71.4% and negative -10.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.16%.
Volatility
Amphastar Pharmaceuticals's last day, last week, and last month's current intraday variation average was 0.32%, 0.72%, and 4.16%, respectively.
Amphastar Pharmaceuticals's highest amplitude of average volatility was 3.45% (day), 3.96% (last week), and 7.30% (last month), respectively.
Amphastar Pharmaceuticals's Stock Yearly Top and Bottom Value
Amphastar Pharmaceuticals's stock is valued at $32.53 at 11:22 EST, way under its 52-week high of $44.46 and way higher than its 52-week low of $17.56.
Amphastar Pharmaceuticals's Moving Average
Amphastar Pharmaceuticals's worth is under its 50-day moving average of $35.60 and way above its 200-day moving average of $27.06.4. Alamo Group (ALG)
11.1% sales growth and 11.87% return on equity
Alamo Group Inc. manufactures, distributes and services infrastructure and agricultural maintenance equipment worldwide.
Alamo Group's sales growth this year is anticipated to be 11.2% and 5.9% for next year.
Year-on-year quarterly revenue growth grew by 16.3%, now sitting on 1.39B for the twelve trailing months.
Volume
Today's last reported volume for Alamo Group is 84854 which is 106.62% above its average volume of 41066.
Alamo Group's sales growth for the next quarter is 11.1%. The company's growth estimates for the ongoing quarter and the next is a negative 0.5% and 35.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.87%.
Volatility
Alamo Group's last day, last week, and last month's current intraday variation average was 3.13%, 2.28%, and 1.46%, respectively.
Alamo Group's highest amplitude of average volatility was 3.05% (day), 3.26% (last week), and 2.68% (last month), respectively.
Alamo Group's Stock Yearly Top and Bottom Value
Alamo Group's stock is valued at $113.27 at 11:22 EST, way below its 52-week high of $160.71 and higher than its 52-week low of $108.35.
Alamo Group's Moving Average
Alamo Group's worth is under its 50-day moving average of $122.11 and way under its 200-day moving average of $140.28.5. Wintrust Financial Corporation (WTFC)
10.9% sales growth and 10.07% return on equity
Wintrust Financial Corporation is a financial holding corporation.
Wintrust Financial Corporation's sales growth this year is anticipated to be 8.6% and 9.6% for next year.
Year-on-year quarterly revenue growth declined by 7.3%, now sitting on 1.73B for the twelve trailing months.
Volume
Today's last reported volume for Wintrust Financial Corporation is 944769 which is 109.53% above its average volume of 450895.
Wintrust Financial Corporation's sales growth for the next quarter is 10.9%. The company's growth estimates for the present quarter and the next is 0.6% and 9.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.07%.
Volatility
Wintrust Financial Corporation's last day, last week, and last month's current intraday variation average was 3.68%, 2.22%, and 1.80%, respectively.
Wintrust Financial Corporation's highest amplitude of average volatility was 2.86% (day), 3.61% (last week), and 3.22% (last month), respectively.
Wintrust Financial Corporation's Stock Yearly Top and Bottom Value
Wintrust Financial Corporation's stock is valued at $81.89 at 11:22 EST, way below its 52-week high of $105.56 and way above its 52-week low of $65.66.
Wintrust Financial Corporation's Moving Average
Wintrust Financial Corporation's value is below its 50-day moving average of $87.86 and under its 200-day moving average of $89.68.6. PennantPark Investment Corporation (PNNT)
9% sales growth and 19.11% return on equity
PennantPark Investment Corporation (Biz Development) is a company that develops businesses.
PennantPark Investment Corporation's sales growth this year is anticipated to be 24.9% and 10.8% for next year.
Year-on-year quarterly revenue growth grew by 51.3%, now sitting on 91.2M for the twelve trailing months.
Volume
Today's last reported volume for PennantPark Investment Corporation is 409445 which is 41.22% above its average volume of 289934.
PennantPark Investment Corporation's sales growth is a negative 0% for the ongoing quarter and 9% for the next. The company's growth estimates for the current quarter and the next is 41.7% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.11%.
Volatility
PennantPark Investment Corporation's last day, last week, and last month's current intraday variation average was 1.59%, 1.00%, and 1.55%, respectively.
PennantPark Investment Corporation's highest amplitude of average volatility was 2.75% (day), 1.83% (last week), and 2.49% (last month), respectively.
PennantPark Investment Corporation's Stock Yearly Top and Bottom Value
PennantPark Investment Corporation's stock is valued at $6.95 at 11:22 EST, way below its 52-week high of $8.02 and way higher than its 52-week low of $6.21.
PennantPark Investment Corporation's Moving Average
PennantPark Investment Corporation's value is below its 50-day moving average of $7.38 and under its 200-day moving average of $7.09.7. Church & Dwight Company (CHD)
5.5% sales growth and 24.38% return on equity
Church & Dwight Co., Inc. designs, produces, and markets specialty household, personal, and other products both in the United States as well as internationally.
Church & Dwight Company's sales growth this year is anticipated to be 5.4% and 3.5% for next year.
Year-on-year quarterly revenue growth grew by 5.7%, now sitting on 5.12B for the twelve trailing months.
Volume
Today's last reported volume for Church & Dwight Company is 997906 which is 28.45% below its average volume of 1394870.
Church & Dwight Company's sales growth for the next quarter is 5.5%. The company's growth estimates for the ongoing quarter and the next is 1.4% and 32.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 24.38%.
Volatility
Church & Dwight Company's last day, last week, and last month's current intraday variation average was 1.04%, 2.22%, and 1.75%, respectively.
Church & Dwight Company's highest amplitude of average volatility was 1.80% (day), 2.78% (last week), and 2.96% (last month), respectively.
Church & Dwight Company's Stock Yearly Top and Bottom Value
Church & Dwight Company's stock is valued at $91.79 at 11:22 EST, below its 52-week high of $96.26 and way above its 52-week low of $77.62.